Tabac pour pipe à eau : Questions médicales fréquentes
Nom anglais: Tobacco, Waterpipe
Descriptor UI:D000073846
Tree Number:J01.637.767.844.750
Termes MeSH sélectionnés :
Patient Reported Outcome Measures
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tabac pour pipe à eau : Questions médicales les plus fréquentes",
"headline": "Tabac pour pipe à eau : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tabac pour pipe à eau : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-20",
"dateModified": "2025-02-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tabac pour pipe à eau"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Produits du tabac",
"url": "https://questionsmedicales.fr/mesh/D062789",
"about": {
"@type": "MedicalCondition",
"name": "Produits du tabac",
"code": {
"@type": "MedicalCode",
"code": "D062789",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J01.637.767.844"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Tabac pour pipe à eau",
"alternateName": "Tobacco, Waterpipe",
"code": {
"@type": "MedicalCode",
"code": "D000073846",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Omar F Khabour",
"url": "https://questionsmedicales.fr/author/Omar%20F%20Khabour",
"affiliation": {
"@type": "Organization",
"name": "Faculty of Applied Medical Sciences, Department of Laboratory Medical Sciences, Jordan University of Science and Technology, Irbid, Jordan."
}
},
{
"@type": "Person",
"name": "Karem H Alzoubi",
"url": "https://questionsmedicales.fr/author/Karem%20H%20Alzoubi",
"affiliation": {
"@type": "Organization",
"name": "Department of Clinical Pharmacy, Jordan University of Science and Technology, Irbid, Jordan."
}
},
{
"@type": "Person",
"name": "Erin L Sutfin",
"url": "https://questionsmedicales.fr/author/Erin%20L%20Sutfin",
"affiliation": {
"@type": "Organization",
"name": "Social Sciences and Health Policy, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA esutfin@wakehealth.edu."
}
},
{
"@type": "Person",
"name": "Jennifer Cornacchione Ross",
"url": "https://questionsmedicales.fr/author/Jennifer%20Cornacchione%20Ross",
"affiliation": {
"@type": "Organization",
"name": "Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA."
}
},
{
"@type": "Person",
"name": "Thomas Eissenberg",
"url": "https://questionsmedicales.fr/author/Thomas%20Eissenberg",
"affiliation": {
"@type": "Organization",
"name": "Department of Psychology, Virginia Commonwealth University, Richmond, VA, United States of America."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Optimizing chronic pain management through patient engagement with quality of life measures: a randomized controlled trial.",
"datePublished": "2022-08-02",
"url": "https://questionsmedicales.fr/article/35918787",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1515/jom-2021-0296"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of a 27-color panel for the detection of measurable residual disease in patients diagnosed with acute myeloid leukemia.",
"datePublished": "2022-07-04",
"url": "https://questionsmedicales.fr/article/35716345",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cyto.a.24667"
}
},
{
"@type": "ScholarlyArticle",
"name": "Suppression of Axial Tremor by Deep Brain Stimulation in Patients with Essential Tremor: Effects on Gait and Balance Measures.",
"datePublished": "2022-07-01",
"url": "https://questionsmedicales.fr/article/35854793",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.5334/tohm.698"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical Correlates of Measured and Predicted Resting Energy Expenditure in Patients with Anorexia Nervosa: A Retrospective Cohort Study.",
"datePublished": "2022-06-30",
"url": "https://questionsmedicales.fr/article/35807906",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/nu14132727"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of Barrett Toric Calculations Using Measured and Predicted Posterior Corneal Astigmatism in Cataract Surgery Patients.",
"datePublished": "2022-06-01",
"url": "https://questionsmedicales.fr/article/35673350",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2147/OPTH.S351011"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Technologie, industrie et agriculture",
"item": "https://questionsmedicales.fr/mesh/D013676"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits manufacturés",
"item": "https://questionsmedicales.fr/mesh/D008420"
},
{
"@type": "ListItem",
"position": 4,
"name": "Dispositifs pour fumer",
"item": "https://questionsmedicales.fr/mesh/D000074602"
},
{
"@type": "ListItem",
"position": 5,
"name": "Produits du tabac",
"item": "https://questionsmedicales.fr/mesh/D062789"
},
{
"@type": "ListItem",
"position": 6,
"name": "Tabac pour pipe à eau",
"item": "https://questionsmedicales.fr/mesh/D000073846"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tabac pour pipe à eau - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tabac pour pipe à eau",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tabac pour pipe à eau",
"description": "Comment diagnostiquer une dépendance au tabac à pipe à eau ?\nQuels tests sont utilisés pour évaluer les effets du tabac à pipe à eau ?",
"url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Patient+Reported+Outcome+Measures&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tabac pour pipe à eau",
"description": "Quels sont les symptômes d'une consommation excessive ?\nComment le tabac à pipe à eau affecte-t-il la santé bucco-dentaire ?",
"url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Patient+Reported+Outcome+Measures&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tabac pour pipe à eau",
"description": "Comment prévenir l'usage du tabac à pipe à eau chez les jeunes ?\nQuelles campagnes sont efficaces contre le tabac à pipe à eau ?",
"url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Patient+Reported+Outcome+Measures&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tabac pour pipe à eau",
"description": "Quels traitements existent pour arrêter le tabac à pipe à eau ?\nLes médicaments peuvent-ils aider à arrêter le tabac à pipe à eau ?",
"url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Patient+Reported+Outcome+Measures&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tabac pour pipe à eau",
"description": "Quelles sont les complications respiratoires liées au tabac à pipe à eau ?\nLe tabac à pipe à eau peut-il causer des maladies cardiovasculaires ?",
"url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Patient+Reported+Outcome+Measures&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tabac pour pipe à eau",
"description": "Quels sont les principaux facteurs de risque du tabac à pipe à eau ?\nLes femmes enceintes sont-elles à risque avec le tabac à pipe à eau ?",
"url": "https://questionsmedicales.fr/mesh/D000073846?mesh_terms=Patient+Reported+Outcome+Measures&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dépendance au tabac à pipe à eau ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic repose sur l'évaluation des habitudes de consommation et des symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les effets du tabac à pipe à eau ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de fonction pulmonaire et des analyses de sang peuvent évaluer les effets sur la santé."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une consommation excessive ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent toux, essoufflement, fatigue et irritation des voies respiratoires."
}
},
{
"@type": "Question",
"name": "Comment le tabac à pipe à eau affecte-t-il la santé bucco-dentaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut causer des maladies des gencives, des caries et des taches sur les dents."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'usage du tabac à pipe à eau chez les jeunes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation sur les risques et la promotion d'activités alternatives sont essentielles."
}
},
{
"@type": "Question",
"name": "Quelles campagnes sont efficaces contre le tabac à pipe à eau ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les campagnes de sensibilisation et les restrictions publicitaires montrent des résultats positifs."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour arrêter le tabac à pipe à eau ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les thérapies comportementales et les substituts nicotiniques."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à arrêter le tabac à pipe à eau ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments comme la varénicline peuvent réduire les envies de fumer."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications respiratoires liées au tabac à pipe à eau ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent bronchite chronique, emphysème et risque accru de cancer du poumon."
}
},
{
"@type": "Question",
"name": "Le tabac à pipe à eau peut-il causer des maladies cardiovasculaires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il augmente le risque de maladies cardiovasculaires en affectant la circulation sanguine."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du tabac à pipe à eau ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le milieu social, et l'exposition à d'autres fumeurs."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles à risque avec le tabac à pipe à eau ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, cela peut nuire au développement fœtal et augmenter les complications de grossesse."
}
}
]
}
]
}
Health-related quality of life (HRQOL) represents a new approach for guiding chronic pain management because it is patient-centered and more likely to be understood and accepted by patients....
To assess the value and utility of an eHealth intervention for patients with chronic low back pain (CLBP) that was primarily based on HRQOL measures and to measure the clinical outcomes associated wit...
A randomized controlled trial was conducted within the Pain Registry for Epidemiological, Clinical, and Interventional Studies and Innovation (PRECISION Pain Research Registry) using participants scre...
There were no significant differences between the experimental and control treatment groups for changes over time in any primary outcome measure. The...
The eHealth intervention studied herein did not achieve statistically significant or clinically important improvements in any of the primary or secondary outcome measures. However, the validity and ge...
Acute myeloid leukemia (AML) measurable residual disease (MRD) evaluated by multiparametric flow cytometry (MFC) is a surrogate for progression-free and overall survival in clinical trials and patient...
Deep brain stimulation (DBS) of the ventralis intermedius (VIM) nucleus of the thalamus has been successful in mitigating upper limb tremor, but the effect on gait and balance performance is unclear. ...
Seventeen ET individuals treated with DBS (ET DBS) and 17 age-and sex-matched healthy controls (HC) performed a postural balance and overground walking task. In separate and consecutive visits, ET DBS...
With DBS OFF, ET DBS exhibited significantly greater stride length variability, sway path length, and tremor during gait and balance task relative to HC. Relative to DBS OFF, DBS ON reduced stride len...
The findings of this study revealed that VIM DBS was effective in improving gait and balance in ET DBS and that improvements in gait and postural balance were associated with a reduction of axial trem...
ET patients exhibit tremor in various body locations during gait and balance.DBS reduced stride length variability and sway path length.DBS-induced improvements in gait and balance were associated wit...
Resting energy expenditure (REE; i.e., the calorie amount required for 24 h during a non-active period) is an important parameter in nutritional rehabilitation of patients with anorexia nervosa (AN). ...
To compare residual astigmatism prediction errors across Barrett toric calculations using predicted posterior corneal astigmatism (PCA) and PCA measured using the IOL Master 700 with total keratometry...
A retrospective cohort study was undertaken on patients with corneal astigmatism and no other ocular comorbidities that underwent uneventful refractive femtosecond laser-assisted cataract surgery with...
A total of 24 eyes, 10 with-the-rule (WTR), 10 against-the-rule (ATR) and 4 oblique astigmatism, from 24 patients were included in this study. PCA ranged from 0.00 to 0.67 D with a mean of 0.24 ± 0.15...
Barrett toric calculations using predicted PCA and PCA measured using IOLM produced comparable residual astigmatism prediction errors. The incorporation of median measurements did not significantly im...
Linezolid (LZD) levels are frequently insufficient in intensive care unit (ICU) patients receiving standard dose, which is predictive of a poor prognosis. Alternative dosing regimens are suggested to ...
Forty-eight patients admitted to the intensive care unit were enrolled in an open-label, prospective, randomized study and assigned to one of three LZD administration modes: intermittent groupI (GpI) ...
Time spent with a drug concentration more than 85% over the minimum inhibitory concentration (T > MIC) was substantially more common in GpII and III than in GpI (P < 0.01). AUC/MIC values greater than...
In critically ill patients, continuous infusion with a loading dose (GpIII) is obviously superior to continuous infusion without a loading dose (GpII) or intermittent infusion (GpI) for infection ther...
Early adversity scales often display insufficient content coverage and typically assess the presence of adversity, but not its severity....
To address some of these limitations, we developed the 13-item Youth and Childhood Adversity Scale. We subsequently revised and expanded the scale regarding content coverage and item wording, resultin...
We conducted one cross-sectional (N = 1498; 43.9 % females; 24.42 years, SD = 3.72, range: 18-30 years) and one longitudinal study (N = 1084; 39.6 % females; 32 years, SD = 10.49, range: 18-75 years)....
Exploratory factor analysis suggested a one-factor model for both the presence/absence and the severity facet, which both displayed good model fit in subsequent confirmatory factor analyses. Factor mo...
The CAM offers a psychometrically-sound, content-wise comprehensive, and free to use assessment of early adversity....
Flatness is a critical parameter in the manufacturing industry, directly impacting the fit and overall product performance. As the efficiency of manufacturing continues to advance, there is an increas...
To understand the experiences of urologists and obstetricians-gynecologists (obgyns) with patient-perpetrated sexual harassment (PPSH) since the clinical focus of these specialists may make them parti...
A multiple-choice anonymous online survey was administered in the Departments of Urology and Obgyn at a single institution from 22 September, 2022-18 October, 2022. The survey assessed if clinicians h...
Majority of respondents reported that they experienced or witnessed PPSH (78%, N = 100). Gender harassment was the most common form of PPSH experienced by clinicians (53%, N = 68). PPSH was most often...
Our study highlights the pervasiveness of PPSH among urologists and obgyns. Future studies should elucidate what policy changes can be effective in protecting clinicians from PPSH....
